Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab Nanoparticles in Colon Cancer
NCT03774680Phase 1Unknown
- Start
- Feb 2020
- Primary completion
- Feb 2020
- Countries
- 2
01
Overview
Phase 1 trial of cetuximab in colorectal cancer (CRC). Primary endpoint: Pharmacokinetics at 1 year. Status: unknown.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03774680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774680.